PBL
MCID: PLS025
MIFTS: 46

Plasmablastic Lymphoma (PBL) malady

Categories: Rare diseases, Blood diseases, Immune diseases

Aliases & Classifications for Plasmablastic Lymphoma

Aliases & Descriptions for Plasmablastic Lymphoma:

Name: Plasmablastic Lymphoma 50 56 69
Immunoblastic Large-Cell Lymphoma 69
Pbl 56

Classifications:



External Ids:

Orphanet 56 ORPHA289666
ICD10 via Orphanet 34 C83.3
UMLS via Orphanet 70 C3472614

Summaries for Plasmablastic Lymphoma

NIH Rare Diseases : 50 plasmablastic lymphoma is an aggressive form of non-hodgkin lymphoma. although the condition most commonly occurs in the oral cavity, it can be diagnosed in many other parts of the body such as the gastrointestinal tract, lymph nodes, and skin. the exact underlying cause of plasmablastic lymphoma is poorly understood; however, it is often associated with suppression of the immune system (i.e. hiv infection, immunosuppressive therapy). there is currently no standard therapy for plasmablastic lymphoma. treatment usually consists of chemotherapy with or without radiation therapy and hematopoietic stem cell transplantation. last updated: 1/18/2016

MalaCards based summary : Plasmablastic Lymphoma, also known as immunoblastic large-cell lymphoma, is related to lymphoma and autoimmune lymphoproliferative syndrome, type iib. An important gene associated with Plasmablastic Lymphoma is PTPRC (Protein Tyrosine Phosphatase, Receptor Type C), and among its related pathways/superpathways are MicroRNAs in cancer and B Cell Receptor Signaling Pathway (sino). The drugs Cyclophosphamide and Thiotepa have been mentioned in the context of this disorder. Affiliated tissues include b cells, skin and lymph node, and related phenotypes are hematopoietic system and cellular

Wikipedia : 71 Plasmablastic lymphoma is a type of large B-cell lymphoma, recognized in the WHO 2008... more...

Related Diseases for Plasmablastic Lymphoma

Diseases related to Plasmablastic Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 100)
id Related Disease Score Top Affiliating Genes
1 lymphoma 10.9
2 autoimmune lymphoproliferative syndrome, type iib 10.9
3 ethmoid sinus inverted papilloma 10.3 BCL6 PTPRC
4 miliaria 10.3 NOTCH1 PTPRC
5 congenital sucrase-isomaltase deficiency with starch and lactose intolerance 10.3 MUC1 PTPRC
6 vagina leiomyosarcoma 10.2 DES MUC1
7 myoma 10.2 DES MUC1
8 invasive malignant thymoma 10.2 DES MUC1
9 spleen angiosarcoma 10.2 DES MUC1
10 marfanoid hypermobility syndrome 10.2 DES MUC1
11 ovarian cystadenoma 10.2 DES MUC1
12 biliary papillomatosis 10.2 DES MUC1
13 tanycytic ependymoma 10.2 DES MUC1
14 appendix mucinous cystadenocarcinoma 10.2 MUC1 PTPRC
15 embryonal testis carcinoma 10.2 MUC1 PTPRC
16 petrous apex meningioma 10.2 DES MUC1
17 vulvar squamous papilloma 10.2 DES MUC1
18 coronary stenosis 10.2 DES MUC1
19 sebaceous adenoma 10.2 DES MUC1
20 spinal cord intramedullary teratoma 10.2 BCL6 PTPRC
21 anal gland neoplasm 10.2 DES MUC1
22 pseudohermaphrodism anorectal anomalies 10.2 DES MUC1
23 lip cancer 10.2 BCL6 MUC1 PTPRC
24 omodysplasia 2 10.1 DES MUC1 PTPRC
25 congenital muscular dystrophy with hyperlaxity 10.1 DES MUC1 PTPRC
26 lung benign neoplasm 10.1 DES MUC1 PTPRC
27 diabetes persistent mullerian ducts 10.1 DES MUC1 PTPRC
28 preretinal fibrosis 10.1 DES MUC1 PTPRC
29 barnicoat baraitser syndrome 10.1 CD38 MS4A1
30 immunodeficiency due to a classical component pathway complement deficiency 10.1 CDKN2A MUC1
31 cd40 ligand deficiency 10.1 CDKN2A PTPRC
32 bladder adenocarcinoma 10.1 CDKN2A MUC1
33 carnitine-acylcarnitine translocase deficiency 10.1 BCL6 MS4A1 PTPRC
34 avian influenza 10.1 CDKN2A MUC1
35 akinetopsia 10.0 CD38 PTPRC
36 acute canaliculitis 10.0 CDKN2A MTOR
37 brain stem medulloblastoma 10.0 CDKN2A NOTCH1
38 b-cell lymphomas 10.0
39 crohn's disease 10.0
40 diffuse large b-cell lymphoma 10.0
41 multiple mitochondrial dysfunctions syndrome 10.0 ABCB1 BCL6
42 house allergic alveolitis 10.0 CDKN2A DES
43 tumor of exocrine pancreas 10.0 CDKN2A MUC1
44 duodenal ulcer 10.0 CD38 NOTCH1
45 penile disease 10.0 BCL6 CDKN2A PTPRC
46 tricuspid valve prolapse 10.0 CDKN2A NOTCH1
47 aicardi-goutieres syndrome 10.0 CDKN2A MUC1
48 testicular fibroma 9.9 ABCB1 CDKN2A
49 hemophagocytic lymphohistiocytosis 9.9 ABCB1 MTOR NOTCH1
50 episodic ataxia 9.9 CDKN2A DES MUC1

Graphical network of the top 20 diseases related to Plasmablastic Lymphoma:



Diseases related to Plasmablastic Lymphoma

Symptoms & Phenotypes for Plasmablastic Lymphoma

MGI Mouse Phenotypes related to Plasmablastic Lymphoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.01 ABCB1 BCL6 CD38 CDKN2A MS4A1 MTOR
2 cellular MP:0005384 10 BCL6 CD38 CDKN2A DES MTOR NOTCH1
3 endocrine/exocrine gland MP:0005379 9.98 ABCB1 BCL6 CD38 CDKN2A MTOR NOTCH1
4 homeostasis/metabolism MP:0005376 9.97 MTOR NOTCH1 PTPRC ABCB1 BCL6 CD38
5 immune system MP:0005387 9.92 ABCB1 BCL6 CD38 CDKN2A MS4A1 MTOR
6 liver/biliary system MP:0005370 9.65 ABCB1 BCL6 CDKN2A NOTCH1 PTPRC
7 muscle MP:0005369 9.55 BCL6 CDKN2A DES MTOR NOTCH1
8 no phenotypic analysis MP:0003012 9.35 ABCB1 BCL6 CDKN2A MTOR PTPRC
9 respiratory system MP:0005388 9.02 BCL6 CDKN2A MTOR NOTCH1 PTPRC

Drugs & Therapeutics for Plasmablastic Lymphoma

Drugs for Plasmablastic Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 452)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
2
Thiotepa Approved Phase 4,Phase 2,Phase 3,Phase 1 52-24-4 5453
3
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
5 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
6 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
8 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
10
Cyclosporine Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
11
Mitoxantrone Approved, Investigational Phase 3,Phase 1,Phase 2 65271-80-9 4212
12
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
13
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
14
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
15
Idarubicin Approved Phase 3 58957-92-9 42890
16
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
17
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
18
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
19
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
20
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
21
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
22
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
23
Fludarabine Approved Phase 2, Phase 3, Phase 1 21679-14-1, 75607-67-9 30751
24
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1,Early Phase 1 55-98-1 2478
25
rituximab Approved Phase 3,Phase 2,Phase 1 174722-31-7 10201696
26
Bleomycin Approved Phase 3,Phase 1,Phase 2 11056-06-7 5360373
27
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
28
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
29
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
30
Mechlorethamine Approved Phase 3,Phase 1,Phase 2 51-75-2 4033
31
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
32
Ofloxacin Approved Phase 3 82419-36-1 4583
33
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613 2171
34
Cefepime Approved Phase 3,Phase 1 88040-23-7 5479537
35
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
36
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
37
Carmustine Approved Phase 3,Phase 1,Phase 2 154-93-8 2578
38
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
39
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
40
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
41
Morphine Approved, Investigational Phase 3 57-27-2 5288826
42
Captopril Approved Phase 3 62571-86-2 44093
43
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
44
Ribavirin Approved Phase 3 36791-04-5 37542
45
Fluconazole Approved Phase 3 86386-73-4 3365
46
Hydrocortisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
47
Ephedrine Approved Phase 3 299-42-3 9294
48
Ondansetron Approved Phase 3,Phase 2 99614-02-5 4595
49
Mesna Approved Phase 3,Phase 1,Phase 2 3375-50-6 598
50
Vancomycin Approved Phase 3 1404-90-6 441141 14969

Interventional clinical trials:

(show top 50) (show all 548)
id Name Status NCT ID Phase
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
3 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3
4 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3
5 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
6 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
7 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3
8 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3
9 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3
10 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3
11 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
12 Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma Completed NCT00002565 Phase 3
13 Combination Chemotherapy in Treating Patients With Lymphoma Completed NCT00002835 Phase 3
14 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
15 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3
16 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
17 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
18 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3
19 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
20 Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Completed NCT00002576 Phase 3
21 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3
22 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
23 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3
24 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
25 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3
26 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
27 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3
28 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3
29 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
30 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3
31 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma Completed NCT00003150 Phase 3
32 Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy Completed NCT00003341 Phase 3
33 Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Completed NCT00005867 Phase 3
34 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
35 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
36 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
37 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
38 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
39 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3
40 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3
41 SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00004031 Phase 3
42 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Completed NCT00438958 Phase 3
43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
44 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
45 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
46 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3
47 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3
48 Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401) Completed NCT00329030 Phase 3
49 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
50 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Completed NCT00369564 Phase 3

Search NIH Clinical Center for Plasmablastic Lymphoma

Genetic Tests for Plasmablastic Lymphoma

Anatomical Context for Plasmablastic Lymphoma

MalaCards organs/tissues related to Plasmablastic Lymphoma:

39
B Cells, Skin, Lymph Node, Bone, Small Intestine, Lung, Breast

Publications for Plasmablastic Lymphoma

Articles related to Plasmablastic Lymphoma:

(show top 50) (show all 276)
id Title Authors Year
1
Primary cutaneous plasmablastic lymphoma presenting as perineal ulcero-proliferative growth in a human immunodeficiency virus-seropositive patient. ( 27779143 )
2017
2
Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1. ( 27687004 )
2017
3
Long-Term Survival of Primary Intracranial Plasmablastic Lymphoma: Case Report and Review of the Literature. ( 27794513 )
2017
4
Clinical Characteristics and Prognostic Factors of Plasmablastic Lymphoma Patients: Analysis of 135 Patients from the Lysa Group. ( 28031174 )
2016
5
A Rare Case of Plasmablastic Lymphoma Mimicking Adenocarcinoma of the Sigmoid Colon. ( 27657558 )
2016
6
Plasmablastic lymphoma of the gallbladder. ( 27059870 )
2016
7
Ileo-ileal Intussusception and Bowel Obstruction Caused by Plasmablastic Lymphoma of Small Bowel- A Rare Entity in Rare Location. ( 27134931 )
2016
8
Primary cutaneous plasmablastic lymphoma revealing clinically unsuspected HIV infection. ( 27579749 )
2016
9
Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma. ( 27966518 )
2016
10
Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib. ( 26715026 )
2016
11
Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis. ( 27684979 )
2016
12
Plasmablastic Lymphoma of Small Intestine: A Rare Case Report with Review of Literature. ( 27408374 )
2016
13
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients. ( 27175027 )
2016
14
Primary Maxillary Sinus Plasmablastic Lymphoma in HIV/AIDS. ( 27735156 )
2016
15
Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases. ( 27604616 )
2016
16
Plasmablastic lymphoma: oral presentation in patient suffering from osteradionecrosis of the jaw. ( 27837702 )
2016
17
Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy. ( 28011983 )
2016
18
Plasmablastic lymphoma involving the stomach in an HIV positive man. ( 26899982 )
2016
19
Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung. ( 27746876 )
2016
20
Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D. ( 28001444 )
2016
21
A rare presentation of plasmablastic lymphoma as cutaneous nodules in an immunocompromised patient. ( 27738277 )
2016
22
Plasmablastic Lymphoma Mimicking Acute Pancreatitis. ( 27034868 )
2016
23
Plasmablastic lymphoma mimicking carcinomatosis: A case report and review of the literature. ( 27900846 )
2016
24
Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma. ( 27164966 )
2016
25
Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma. ( 27957358 )
2016
26
Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma. ( 27012155 )
2016
27
Richter Syndrome With Plasmablastic Lymphoma at Primary Diagnosis: A Case Report With a Review of the Literature. ( 27801729 )
2016
28
Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature. ( 27034819 )
2016
29
Erratum to cardiac obstruction secondary to metastatic invasion - A rare complication of Human Herpes Virus 8-positive plasmablastic lymphoma in acquired immunodeficiency syndrome. ( 27867656 )
2016
30
Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity. ( 27617520 )
2016
31
Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. ( 26795083 )
2016
32
Human immunodeficiency virus associated plasmablastic lymphoma: A case report. ( 27795651 )
2016
33
Aberrant expression of T-cell marker CD7 in HIV negative intestinal plasmablastic lymphoma. ( 27788919 )
2016
34
Solitary plasmablastic lymphoma in the esophagus. ( 26925582 )
2016
35
Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient: A case report. ( 27428232 )
2016
36
Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings. ( 27324386 )
2016
37
Primary testicular plasmablastic lymphoma: unique case in a 30 year old. ( 27121529 )
2016
38
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma. ( 26801792 )
2016
39
Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions. ( 26607603 )
2016
40
Retracted: Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions. ( 27110244 )
2016
41
Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report. ( 27408991 )
2016
42
Autologous Hematopoietic Stem Cell Transplantation for Plasmablastic Lymphoma: The European Society for Blood and Marrow Transplantation Experience. ( 25783635 )
2015
43
Primary Posttransplant Plasmablastic Lymphoma of the Tongue: Report of a Case With Immunohistochemical and Molecular Studies. ( 26258627 )
2015
44
The biology and treatment of plasmablastic lymphoma. ( 25636338 )
2015
45
A unique presentation of unilateral pleural effusion in a patient with plasmablastic lymphoma. ( 25686646 )
2015
46
Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs. ( 25921246 )
2015
47
Rare presentation of orbital plasmablastic lymphoma with oral cavity involvement in an HIV-negative patient. ( 26376702 )
2015
48
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. ( 26055271 )
2015
49
Jejunal plasmablastic lymphoma presenting as obscure overt gastrointestinal bleeding: diagnosis by wireless capsule endoscopy. ( 26334464 )
2015
50
Case of plasmablastic lymphoma of the sigmoid colon and literature review. ( 26140010 )
2015

Variations for Plasmablastic Lymphoma

Expression for Plasmablastic Lymphoma

Search GEO for disease gene expression data for Plasmablastic Lymphoma.

Pathways for Plasmablastic Lymphoma

Pathways related to Plasmablastic Lymphoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 12.03 ABCB1 CDKN2A MTOR NOTCH1
2
Show member pathways
11.83 BCL6 MTOR PTPRC
3 11.32 CD38 MS4A1 NOTCH1 PTPRC
4 11.21 CD38 MS4A1 PTPRC
5 10.65 BCL6 CD38 MS4A1 PTPRC

GO Terms for Plasmablastic Lymphoma

Cellular components related to Plasmablastic Lymphoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 8.92 ABCB1 CD38 NOTCH1 PTPRC

Biological processes related to Plasmablastic Lymphoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of transcription, DNA-templated GO:0045892 9.56 BCL6 CD38 CDKN2A NOTCH1
2 positive regulation of epithelial to mesenchymal transition GO:0010718 9.37 MTOR NOTCH1
3 B cell proliferation GO:0042100 9.32 MS4A1 PTPRC
4 negative regulation of cell-matrix adhesion GO:0001953 9.16 BCL6 CDKN2A
5 somatic stem cell division GO:0048103 8.96 CDKN2A NOTCH1
6 positive regulation of B cell proliferation GO:0030890 8.8 BCL6 CD38 PTPRC

Sources for Plasmablastic Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....